A study has shown that the siRNA knockdown of either IDH1 or IDH2 can significantly reduce the proliferative capacity of a glioblastoma cell line expressing both wild-type IDH1 and IDH2 [30]. The gene discussed is IDH1; the disease is glioblastoma.